ArticleFrontiers in medicine2025

Safety assessment of gemtuzumab ozogamicin: real-world adverse event analysis based on the FDA Adverse Event Reporting System.

Xuexue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.